息医学中的药物治疗 - - 一个十年的证据:文献计量综述
Júlia Raso1, Fabiana Rossi Varallo2
1Department of Pharmaceutical Sciences, School of Pharmaceutical Sciences of Ribeirão Preto, University of Sao Paulo, Ribeirão Preto, Brazil juliaraso@usp.br.
BMJ supportive & palliative care
|December 4, 2025
概括
息治疗 (PC) 中的药物治疗是分散的,阻碍了最佳的药物管理. 未来的研究应该集中在息性药物治疗上,以改善终身护理和解决多药学问题.
科学领域:
- 药理学 药理学是指药理学的学科.
- 抚慰性护理是一种缓解性护理.
- 图书统计学 图书统计学
背景情况:
- 药物治疗在息治疗 (PC) 中至关重要,但往往会导致负面结果的多药.
- 关于PC药理干预的现有科学文献是稀缺和分散的.
- 本综述绘制了PC中药理干预的景观.
研究的目的:
- 探索和绘制有关息治疗中药理干预的科学文献.
- 为了确定趋势,作者,关键词,和在息药物治疗研究的主题演变.
主要方法:
- 一个使用Scopus和Web of Science数据 (2014-2024) 的文献统计综述.
- 包括专注于PC和药物使用的原始文章和评论.
- 使用RStudio和VOSviewer进行分析,以查看出版趋势和关键词演变.
主要成果:
- 分析了2245篇出版物,主要是原创文章 (80%),临床试验有限 (10%).
- "症状管理"是一个主要的关键词,自2019年以来",减药"和"多药"是增长的趋势.
- 息性药物治疗还不是一个整合的研究领域,经常出现在更广泛的背景下.
结论:
- 碎片化阻碍了管理不合适药物的进展,并优化了终生药物治疗.
- 需要进一步的研究来解决治疗合理化和药物经济影响.
- 息性药疗是未来文献发展的重要领域.
更多相关视频
相关概念视频
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Pharmacodynamics in Geriatric Patients: Effects of Age
180
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
180
Combination Therapies and Personalized Medicine
5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Drug Dosing: Geriatric Patients
212
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
212
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
212
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
212
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K


